Spicyip Tidbits

1. IndiaFalls Five Places in the Global Economic Forum

India has fallen five notches in the latest annual rankings of the Global Competitiveness Report released by the World Economic Forum. India was placed 48 in the list of 131 economies covered under the Global Competitiveness Index (GCI) which tracks twelve parameters to come out with the rankings. Among the top emerging markets, India is second this year behind China.

The quality of the business environment in India has improved tangibly in recent years, with increased efficiency of goods, labour and financial markets and greater innovation and sophistication of firm operations. However, a number of weaknesses persist that need to be addressed especially in the area of infrastructure quality. Moreover, dealing with shortcomings in the provision of health services and education will ensure that the benefits of economic growth are more broadly distributed,” said World Economic Forum’s head of strategic insight teams, Fiona Paua. indianpad

2. HC summons Tarun Tejpal for copyright violation

The Delhi High Court has summoned Tehelka editor-in-chief Tarun Tejpal and his sister Neena Tejpal in a case filed by well-known painter Raghu Vyas seeking damages of

Rs one crore for allegedly infringing his copyright of one of his paintings.

Justice S N Agrawal also restrained Tejpals from selling and reproducing the painting titled “The Realm of Bliss”.

The painter, in his suit, contended that he signed an agreement with Tehelka for participating in an auction titled ‘Art of Freedom’ at London organised by Bonhams, an auction house of UK, in association with Tehelka and Aman Nath on July 11.

“After the agreement, Vyas in collaboration with Bollywood actor Manisha Koirala painted a piece titled ‘Realm of Bliss’ for the said auction which was handed over to Tehelka in April 2007,” the suit said.

Contending that he owns the exclusive intellectual property rights in the painting, Vyas also submitted before the court that the painting has still not been returned to him and he fears that it might be copied by the defendants (Tehelka and others).dnaindia.com.

3, Nano Science Mission plans 1000 Crore Investment.

Eco System to make India global hub for R&D

The Nano Science and Technology Mission has planned an investment of ($254 million) Rs 1,000 crore to create an ecosystem to make India a global hub for research and development in nanotechnology, announced Dr T. Ramasami, Secretary, Department of Science and Technology, in the city on Monday.Business Line

4. Bill to be introduced in Parliament providing incentives to scientists.

Union minister for science and technology Mr. Kapil Sibal announced that the Centre would bring a new legislation in the next Budget session of Parliament providing for payment of royalties and share in license fees for scientists who patent their innovations.
The proposal is that researchers of public sector R&D institutions be paid 30 per cent royalty once their patented products are commercialised. Such an incentive-based approach would help create more patents, he said after laying the foundation stone for the Clinical Research Facility for stem cells and regenerative medicines. the first of its kind in India.

Recall Spicyip Tidbits Post and Comments by Shamnad Basheer.

7. Wipro Files Patents for e-Enabler

Wipro Technologies has filed patents for e-enabler .a kit that enables rapid development and deployment of Service Oriented Architecture.

8. Pharma Buzz.

(a)India Scores over China in U.S Generic Market.

(b)New Licenses for 78 Drug Combos

(c)Indian Companies to withdraw to 120 suspect combo drugs

9. Snippets from the International Scene.

(a)U.S continuations rules on hold

A day before the new rules were to take effect,Glaxo Smithkline ahs persuaded a court in Virginia to stop the PTO from implementing controversial new rules on patent claims and continuations.

This move has been welcomed by IP practitioners who were concerned about the impact of the rules on their patenting strategies.

(b)Thailand: 20 More Drugs in Pipeline for Compulsory Licensing.

Thailand has in its pipeline about 20 more items of various patented drugs that could be candidates for compulsory licences, allowing the government to exercise its right over the patent owners to cut prices and make the medicines more available to the publi


About The Author

Leave a Comment

Scroll to Top